16 results
PRE 14A
w964s
17 Apr 20
Preliminary proxy
4:18pm
8-K
EX-99.1
iuty bof2hep58
13 Apr 20
ENDRA Life Sciences Announces Cash Strategy and Business Update in Response to COVID-19
4:29pm
8-K
EX-99.1
sygq33l
10 Mar 20
ENDRA Life Sciences Receives CE Mark for its TAEUS® Clinical Product Targeting Non-Alcoholic Fatty Liver Disease
8:02am
DEF 14A
b0wqz1xc0 zb7duw
10 May 18
Definitive proxy
4:08pm
10-K
q5gul
20 Mar 18
Annual report
12:00am
10-Q
irar 632hhz15
21 Jun 17
Quarterly report
12:00am
- Prev
- 1
- Next